0001209191-23-052775.txt : 20231013 0001209191-23-052775.hdr.sgml : 20231013 20231013162534 ACCESSION NUMBER: 0001209191-23-052775 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230310 FILED AS OF DATE: 20231013 DATE AS OF CHANGE: 20231013 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: De Witte Jan CENTRAL INDEX KEY: 0001776929 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 000-26224 FILM NUMBER: 231325308 MAIL ADDRESS: STREET 1: C/O RESMED INC. STREET 2: 9001 SPECTRUM CENTER BLVD. CITY: SAN DIEGO STATE: CA ZIP: 92123 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: INTEGRA LIFESCIENCES HOLDINGS CORP CENTRAL INDEX KEY: 0000917520 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 510317849 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1100 CAMPUS ROAD CITY: PRINCETON STATE: NJ ZIP: 08540 BUSINESS PHONE: 6092750500 MAIL ADDRESS: STREET 1: 1100 CAMPUS ROAD CITY: PRINCETON STATE: NJ ZIP: 08540 FORMER COMPANY: FORMER CONFORMED NAME: INTEGRA LIFESCIENCES CORP DATE OF NAME CHANGE: 19950614 4/A 1 doc4a.xml FORM 4/A SUBMISSION X0508 4/A 2023-03-10 2023-03-14 0 0000917520 INTEGRA LIFESCIENCES HOLDINGS CORP IART 0001776929 De Witte Jan 1100 CAMPUS ROAD PRINCETON NJ 08540 1 1 0 0 President & CEO 0 Common Stock 2023-03-11 4 M 0 205 0.00 A 5211 D Common Stock 2023-03-11 4 F 0 205 52.87 D 5006 D Restricted Stock Units 0.00 2023-03-11 4 M 0 205 0.00 D Common Stock 205 99828 D This transaction was inadvertently omitted from the Reporting Person's Form 4 filed on March 14, 2023. The award was a restricted stock unit award which will vest in three equal annual installments on the first, second and third anniversaries of the grant date of 3/11/2022 which shall be delivered to the Reporting Person within 30 days following the first business day that occurs immediately following the six month period after the date of his separation of service as deferred compensation. Pursuant to Instruction 9 to Form 4, the Reporting Person has omitted from this amendment to the Form 4 the transaction information with respect to the other shares of the Issuer that were reported in the initial filing of the Form 4 and which are not being amended hereby. /s/ Eric Schwartz; Attorney-in-Fact 2023-10-13